Pulmonary Drug Delivery Devices Market : Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Jun 2022| TMR873B| Transparency

Report Highlights

Pulmonary Drug Delivery Devices Market – Scope of Report

TMR’s report on the global pulmonary drug delivery devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global pulmonary drug delivery devices market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global pulmonary drug delivery devices market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the pulmonary drug delivery devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global pulmonary drug delivery devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global pulmonary drug delivery devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global pulmonary drug delivery devices market.

The report delves into the competitive landscape of the global pulmonary drug delivery devices market. Key players operating in the global pulmonary drug delivery devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global pulmonary drug delivery devices market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market pulmonary drug delivery devices.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

  • Industry Sources:
  • WorldWideScience.org
  • Elsevier, Inc.
  • National Institutes of Health (NIH)
  • PubMed
  • NCBI
  • Department of Health Care Service
  • Trade Data Sources
  • Trade Map
  • UN Comtrade
  • Trade Atlas
  • Company Information
  • OneSource Business Browser
  • Hoover’s
  • Factiva
  • Bloomberg
  • Mergers & Acquisitions
  • Thomson Mergers & Acquisitions
  • MergerStat
  • Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd.
  • IBA Worldwide
  • Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

  • Table 1 : Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Product Type, 2017–2031
  • Table 2 : Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler), 2017–2031
  • Table 3 : Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler), 2017–2031
  • Table 4 : Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Nebulizer), 2017–2031
  • Table 5 : Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031
  • Table 6 : Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017-2031
  • Table 7 : Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Region, 2017–2031
  • Table 8 : North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2017–2031
  • Table 9 : North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Dry Powder Inhalers (Product) 2017–2031
  • Table 10 : North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Metered Dose Inhalers (Product) 2017–2031
  • Table 11 : North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Nebulizers (Product) 2017–2031
  • Table 12 : North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031
  • Table 13 : North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel 2017–2031
  • Table 14 : North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country, 2017–2031
  • Table 15 : Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2017–2031
  • Table 16 : Europe Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2017–2031
  • Table 17 : Europe Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2017–2031
  • Table 18 : Europe Pulmonary Drug Delivery Devices and Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2017–2031
  • Table 19 : Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031
  • Table 20 : Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017–2031
  • Table 21 : Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country/Sub-region, 2017–2031
  • Table 22 : Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2017–2031
  • Table 23 : Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2017–2031
  • Table 24 : Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2017–2031
  • Table 25 : Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2017–2031
  • Table 26 : Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031
  • Table 27 : Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017–2031
  • Table 28 : Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country/Sub-region, 2017–2031
  • Table 29 : Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2017–2031
  • Table 30 : Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2017–2031
  • Table 31 : Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2017–2031
  • Table 32 : Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2017–2031
  • Table 33 : Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031
  • Table 34 : Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017–2031
  • Table 35 : Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country/Sub-region, 2017–2031
  • Table 36 : Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2017–2031
  • Table 37 : Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2017–2031
  • Table 38 : Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2017–2031
  • Table 39 : Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2017–2031
  • Table 40 : Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031
  • Table 41 : Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017–2031
  • Table 42 : Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country/Sub-region, 2017–2031
  • Figure 1 : Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2017–2031
  • Figure 2 : Global Dry Powder Inhalers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017-2031
  • Figure 3 : Global Dry Powder Inhalers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031
  • Figure 4 : Global Metered Dose Inhalers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017–2031
  • Figure 5 : Global Metered Dose Inhalers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031
  • Figure 6 : Global Nebulizers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017–2031
  • Figure 7 : Global Nebulizers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031
  • Figure 8 : Global Single Dose Inhaler Market Volume and Y-o-Y Growth (%), 2017–2031
  • Figure 9 : Global Multi Dose Inhaler Market Volume and Y-o-Y Growth (%), 2017-2031
  • Figure 10 : Global Manually-actuated pressurized inhaler Market Volume and Y-o-Y Growth (%), 2017–2031
  • Figure 11 : Global Breath-actuated pressurized inhaler Market Volume and Y-o-Y Growth (%), 2017-2031
  • Figure 12 : Global Jet Nebulizers Market Volume and Y-o-Y Growth (%), 2017–2031
  • Figure 13 : Global Ultrasonic Wave Nebulizers Market Volume and Y-o-Y Growth (%), 2017-2031
  • Figure 14 : Global Vibrating Mesh Nebulizers Market Volume and Y-o-Y Growth (%), 2017-2031
  • Figure 15 : Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type
  • Figure 16 : Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2017–2031
  • Figure 17 : Global Asthma Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017-2031
  • Figure 18 : Asthma Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031
  • Figure 19 : Global COPD Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017-2031
  • Figure 20 : COPD Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031
  • Figure 21 : Global Cystic Fibrosis Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017-2031
  • Figure 22 : Cystic Fibrosis Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031
  • Figure 23 : Global Others Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017-2031
  • Figure 24 : Others Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031
  • Figure 25 : Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application
  • Figure 26 : Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2017–2031
  • Figure 27 : Global Retail Pharmacies Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017-2031
  • Figure 28 : Retail Pharmacies Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031
  • Figure 29 : Global Hospital Pharmacies Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017-2031
  • Figure 30 : Global E-commerce Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017-2031
  • Figure 31 : E-commerce Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031
  • Figure 32 : Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel
  • Figure 33 : Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Region, 2017–2031
  • Figure 34 : Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Region
  • Figure 35 : North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2017-2031
  • Figure 36 : North America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2017–2031
  • Figure 37 : North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country
  • Figure 38 : North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product, 2017–2031
  • Figure 39 : North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2017–2031
  • Figure 40 : North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2017–2031
  • Figure 41 : North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2017–2031
  • Figure 42 : North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 43 : North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 44 : North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 45 : Europe Pulmonary drug delivery devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2017-2031
  • Figure 46 : Europe Pulmonary drug delivery devices Market Size and Volume Y-o-Y Growth Projections, 2017–2031
  • Figure 47 : Europe Pulmonary drug delivery devices Market Attractiveness Analysis, by Country/Sub-region
  • Figure 48 : Europe Market Value Share Analysis, by Product Type, 2017–2031
  • Figure 49 : Europe Market Value Share Analysis, by Application, 2017–2031
  • Figure 50 : Europe Market Value Share Analysis, by Distribution Channel, 2017–2031
  • Figure 51 : Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2017–2031
  • Figure 52 : Europe Market Attractiveness Analysis, by Product Type, 2022–2031
  • Figure 53 : Europe Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 54 : Europe Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 55 : Asia Pacific Pulmonary drug delivery devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2017-2031
  • Figure 56 : Asia Pacific Pulmonary drug delivery devices Market Y-o-Y Analysis, by Country
  • Figure 57 : Asia Pacific Market Attractiveness Analysis, by Country/Sub-region , 2022–2031
  • Figure 58 : Asia Pacific Market Value Share Analysis, by Product Type, 2017–2031
  • Figure 59 : Asia Pacific Market Value Share Analysis, by Application, 2017–2031
  • Figure 60 : Asia Pacific Market Value Share Analysis, by Distribution Channel, 2017–2031
  • Figure 61 : Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2017–2031
  • Figure 62 : Asia Pacific Market Attractiveness Analysis, by Product Type, 2022–2031
  • Figure 63 : Asia Pacific Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 64 : Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 65 : Latin Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million units) Forecast, 2017-2031
  • Figure 66 : Latin America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2017–2031
  • Figure 67 : Latin America Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 68 : Latin America Market Value Share Analysis, by Product Type, 2017–2031
  • Figure 69 : Latin America Market Value Share Analysis, by Application, 2017–2031
  • Figure 70 : Latin America Market Value Share Analysis, by Distribution Channel, 2017–2031
  • Figure 71 : Latin America Market Value Share Analysis, by Country/Sub-region, 2017–2031
  • Figure 72 : Latin America Market Attractiveness Analysis, by Product Type, 2022–2031
  • Figure 73 : Latin America Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 74 : Latin America Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 75 : MEA Market Size Value (US$ Mn) and Volume (Million Units) Forecast, 2017-2031
  • Figure 76 : MEA Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2017–2031
  • Figure 77 : Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 78 : Middle East & Africa Market Value Share Analysis, by Product Type, 2017–2031
  • Figure 79 : Middle East & Africa Market Value Share Analysis, by Application, 2017–2031
  • Figure 80 : Middle East & Africa Market Value Share Analysis, by Distribution Channel, 2017–2031
  • Figure 81 : Middle East & Africa Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2017–2031
  • Figure 82 : Middle East & Africa Market Attractiveness Analysis, by Product Type, 2022–2031
  • Figure 83 : Middle East & Africa Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 84 : Middle East & Africa Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 85 : Global Pulmonary Drug Delivery Devices Market Share Analysis, by Company, 2021

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Similar Reports from Transparency

Pulmonary Drug Delivery Devices Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

  • Date - Aug 2018
  • Code - TMR873A

Global Pulmonary Drug Delivery Devices Market: Overview

The pulmonary route of administration has proven to be effective in local and systemic delivery of miscellaneous drugs and biopharmaceuticals to treat pulmonary and non-pulmonary diseases. Inhalation therapy is the best option to treat to treat lung diseases such as asthma and cystic fibrosis. The global pulmonary drug delivery devices market is ...

Transparency
Price: $5795

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS